BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 25480336)

  • 1. Differential and opposing effects of imatinib on LPS- and ventilator-induced lung injury.
    Letsiou E; Rizzo AN; Sammani S; Naureckas P; Jacobson JR; Garcia JG; Dudek SM
    Am J Physiol Lung Cell Mol Physiol; 2015 Feb; 308(3):L259-69. PubMed ID: 25480336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imatinib attenuates inflammation and vascular leak in a clinically relevant two-hit model of acute lung injury.
    Rizzo AN; Sammani S; Esquinca AE; Jacobson JR; Garcia JG; Letsiou E; Dudek SM
    Am J Physiol Lung Cell Mol Physiol; 2015 Dec; 309(11):L1294-304. PubMed ID: 26432864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abl family kinases regulate endothelial barrier function in vitro and in mice.
    Chislock EM; Pendergast AM
    PLoS One; 2013; 8(12):e85231. PubMed ID: 24367707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arg mediates LPS-induced disruption of the pulmonary endothelial barrier.
    Rizzo AN; Belvitch P; Demeritte R; Garcia JGN; Letsiou E; Dudek SM
    Vascul Pharmacol; 2020; 128-129():106677. PubMed ID: 32240815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathologic mechanical stress and endotoxin exposure increases lung endothelial microparticle shedding.
    Letsiou E; Sammani S; Zhang W; Zhou T; Quijada H; Moreno-Vinasco L; Dudek SM; Garcia JG
    Am J Respir Cell Mol Biol; 2015 Feb; 52(2):193-204. PubMed ID: 25029266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective treatment of edema and endothelial barrier dysfunction with imatinib.
    Aman J; van Bezu J; Damanafshan A; Huveneers S; Eringa EC; Vogel SM; Groeneveld AB; Vonk Noordegraaf A; van Hinsbergh VW; van Nieuw Amerongen GP
    Circulation; 2012 Dec; 126(23):2728-38. PubMed ID: 23099479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein kinase G increases antioxidant function in lung microvascular endothelial cells by inhibiting the c-Abl tyrosine kinase.
    Stephens RS; Servinsky LE; Rentsendorj O; Kolb TM; Pfeifer A; Pearse DB
    Am J Physiol Cell Physiol; 2014 Mar; 306(6):C559-69. PubMed ID: 24401847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Abl kinases to regulate vascular leak during sepsis and acute respiratory distress syndrome.
    Rizzo AN; Aman J; van Nieuw Amerongen GP; Dudek SM
    Arterioscler Thromb Vasc Biol; 2015 May; 35(5):1071-9. PubMed ID: 25814671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sevoflurane prevents lipopolysaccharide-induced barrier dysfunction in human lung microvascular endothelial cells: Rho-mediated alterations of VE-cadherin.
    Huang Y; Tan Q; Chen R; Cao B; Li W
    Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):119-24. PubMed ID: 26529544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-Abl mediated tyrosine phosphorylation of paxillin regulates LPS-induced endothelial dysfunction and lung injury.
    Fu P; Usatyuk PV; Lele A; Harijith A; Gregorio CC; Garcia JG; Salgia R; Natarajan V
    Am J Physiol Lung Cell Mol Physiol; 2015 May; 308(10):L1025-38. PubMed ID: 25795725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung endothelial barrier protection by iloprost in the 2-hit models of ventilator-induced lung injury (VILI) involves inhibition of Rho signaling.
    Birukova AA; Fu P; Xing J; Cokic I; Birukov KG
    Transl Res; 2010 Jan; 155(1):44-54. PubMed ID: 20004361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of tyrosine kinase inhibitors, imatinib and nilotinib, in murine lipopolysaccharide-induced acute lung injury during neutropenia recovery.
    Kim IK; Rhee CK; Yeo CD; Kang HH; Lee DG; Lee SH; Kim JW
    Crit Care; 2013 Jun; 17(3):R114. PubMed ID: 23787115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-muscle myosin light chain kinase isoform is a viable molecular target in acute inflammatory lung injury.
    Mirzapoiazova T; Moitra J; Moreno-Vinasco L; Sammani S; Turner JR; Chiang ET; Evenoski C; Wang T; Singleton PA; Huang Y; Lussier YA; Watterson DM; Dudek SM; Garcia JG
    Am J Respir Cell Mol Biol; 2011 Jan; 44(1):40-52. PubMed ID: 20139351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical analysis of platelet-derived growth factor receptor-alpha, -beta, c-kit, c-abl, and arg proteins in glioblastoma: possible implications for patient selection for imatinib mesylate therapy.
    Haberler C; Gelpi E; Marosi C; Rössler K; Birner P; Budka H; Hainfellner JA
    J Neurooncol; 2006 Jan; 76(2):105-9. PubMed ID: 16205964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Krev Interaction Trapped-1 in Prostacyclin-Induced Protection against Lung Vascular Permeability Induced by Excessive Mechanical Forces and Thrombin Receptor Activating Peptide 6.
    Meliton A; Meng F; Tian Y; Shah AA; Birukova AA; Birukov KG
    Am J Respir Cell Mol Biol; 2015 Dec; 53(6):834-43. PubMed ID: 25923142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic high-magnitude cyclic stretch stimulates EC inflammatory response via VEGF receptor 2-dependent mechanism.
    Gawlak G; Son S; Tian Y; O'Donnell JJ; Birukov KG; Birukova AA
    Am J Physiol Lung Cell Mol Physiol; 2016 Jun; 310(11):L1062-70. PubMed ID: 26993523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis.
    Daniels CE; Wilkes MC; Edens M; Kottom TJ; Murphy SJ; Limper AH; Leof EB
    J Clin Invest; 2004 Nov; 114(9):1308-16. PubMed ID: 15520863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phospholipase C-ε signaling mediates endothelial cell inflammation and barrier disruption in acute lung injury.
    Bijli KM; Fazal F; Slavin SA; Leonard A; Grose V; Alexander WB; Smrcka AV; Rahman A
    Am J Physiol Lung Cell Mol Physiol; 2016 Aug; 311(2):L517-24. PubMed ID: 27371732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of Rho signaling by pathologic mechanical stretch is a "second hit" to Rho-independent lung injury induced by IL-6.
    Birukova AA; Tian Y; Meliton A; Leff A; Wu T; Birukov KG
    Am J Physiol Lung Cell Mol Physiol; 2012 May; 302(9):L965-75. PubMed ID: 22345573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imatinib mesylate blocks a non-Smad TGF-beta pathway and reduces renal fibrogenesis in vivo.
    Wang S; Wilkes MC; Leof EB; Hirschberg R
    FASEB J; 2005 Jan; 19(1):1-11. PubMed ID: 15629889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.